The benefits of discussing adjuvant therapies one at a time instead of all at once

Author： Zikmund-Fisher Brian   Angott Andrea   Ubel Peter  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.129, Iss.1, 2011-08, pp. : 79-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy

By Henry N.  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 751-753

Springer Publishing Company

Access to resources Recommend Favorite

One Size Does Not Fit All: Personalized Immune Therapies Poised to Take Center Stage

By Azvolinsky Anna  

Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. : 583-584

Oxford University Press

Access to resources Recommend Favorite

Adjuvant and Neoadjuvant Therapies of Pancreatic Cancer: A Review

By Harris Jules   Bruckner Howard  

International Journal of Gastrointestinal Cancer, Vol. 29, Iss. 1, 2001-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Adjuvant Tamoxifen: The Risks Versus the Benefits of Long-Term Therapy

By Schlesinger K.W.   Vogel V.G.  

American Journal of Cancer, Vol. 1, Iss. 6, 2002-01 ,pp. : 375-386

Adis International

Access to resources Recommend Favorite

Adjuvant bisphosphonates in breast cancer: has the time come?

By Gagliato Debora   Chavez-MacGregor Mariana  

Breast Cancer Management, Vol. 2, Iss. 4, 2013-07 ,pp. : 327-337

Future Medicine

Access to resources Recommend Favorite